Merck Sharp & Dohme

Contact
merck.com
+1908-423-1000

Merck & Co., Inc.

One Merck Drive, P.O. Box 100
08889-0100 White House Station
USA
+1908-423-1000
merck.com
Contact
Profile Products News
Contact

About Merck Sharp & Dohme

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them.

Read more about Merck Sharp & Dohme
Facts about Merck Sharp & Dohme
  • Focus : Manufacturer
  • Employees: 10,001+
  • Industry : Pharma

Product portfolio of Merck Sharp & Dohme

Product portfolio

Show all

News about Merck Sharp & Dohme

Merck Sharp & Dohme

18-Apr-2023 | business & finance

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences

Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (Prometheus) announced that the companies have entered into a ...

Read news
Merck Sharp & Dohme

23-Nov-2022 | business & finance

Merck to Acquire Imago BioSciences, Inc. for $1.35 Billion

Acquisition expands Merck’s growing hematology portfolio

Read news
Merck Sharp & Dohme

22-Feb-2022 | business & finance

Curve Therapeutics Announces Collaboration with MSD for Next Generation Drug Discovery Platform

Potentially game-changing platform enables direct discovery of functionally active molecules

Read news
Merck Sharp & Dohme

26-Jan-2021 | research and development

Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates

Company continues Development of Two Investigational Therapeutic Candidates

Read news
Merck Sharp & Dohme

16-Sep-2020 | business & finance

Seattle Genetics and Merck & Co Announce Two Strategic Oncology Collaborations

Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock

Read news
Merck Sharp & Dohme

27-May-2020 | business & finance

Vienna vaccine start-up to be acquired by MSD

Acquisition is expected to accelerate the development of a COVID-19 vaccine candidate

Read news
Merck Sharp & Dohme

21-Jul-2017 | manufacturing

Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

Merck & Co., Pfizer and Corning Incorporated announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction ...

Read news
Merck Sharp & Dohme

28-Oct-2016 | business & finance

Merck prices EUR 1.0 billion debt offering

Merck & Co., Inc., known as MSD outside the United States and Canada, priced today a EUR 1.0 billion public offering of two series of Euro-denominated ...

Read news
Show more news about Merck Sharp & Dohme

Here you will find Merck & Co., Inc.